Internal standard solution for extracting fat-soluble vitamins in serum or plasma, pretreatment reagent for detection and pretreatment method
By using internal standard solutions of methanol, acetonitrile, isopropanol and modified agents in serum or plasma, combined with protein precipitant agents, the problems of cumbersome pretreatment methods and low detection sensitivity in serum or plasma are solved, and high Accuracy and high recovery detection effects and simplify the detection process.
Patent Information
- Application Number
- CN202411240880.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-05
- Publication Date
- 2024-11-12
AI Technical Summary
The existing pretreatment methods for fat-soluble vitamin samples in serum or plasma are complicated, the cost of consumables is high, and the accuracy and recovery of reference substances are low, resulting in low detection sensitivity and easy blockage of pipelines or chromatographic columns, affecting high throughput and automated inspection.
Provide an internal standard solution, including methanol, acetonitrile, isopropanol and an improved agent, with a volume ratio of (28-32)%: (5-20)%: (50-65)%, and an antioxidant is added to bind protein precipitation. Agents for the extraction and detection pretreatment of fat-soluble vitamins in serum or plasma.
It improves the accuracy and recovery of reference substances, improves the sensitivity of detection, and extends the validity period of the internal standard solution, reduces the risks of pipeline blockage and column blockage, and simplifies the detection process.
Smart Images

Figure BDA0005029226260000061 
Figure BDA0005029226260000062 
Figure BDA0005029226260000071
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of chemical analysis, in particular to an internal standard solution for extracting fat-soluble vitamins in serum or plasma, a pretreatment reagent for detection and a pretreatment method. Background Art
[0002] Fat-soluble vitamins are micronutrients necessary for the human body to maintain optimal metabolism, mainly including vitamin A, vitamin D, and vitamin E. With the deepening of research, the role of fat-soluble vitamins is no longer limited to people's initial understanding, such as night blindness [vitamin A (VA) deficiency], osteomalacia (vitamin D deficiency), abnormal oxidative stress [vitamin E (VE) deficiency], etc., but it has been found that abnormal changes in fat-soluble vitamins are related to more and more diseases and other physiological conditions. Studies have shown that VA can promote the development of the immune system and enhance immunity. Its low content is even related to early adult obesity; vitamin D has a certain role in the prevention of certain mental illnesses and diabetes; appropriate concentrations of VE are helpful for cancer prevention and the treatment of diabetic nephropathy and non-alcoholic fatty liver.
[0003] Existing sample pretreatment methods for the detection of fat-soluble vitamins in serum by high performance liquid chromatography-tandem mass spectrometry mainly use liquid-liquid extraction, solid-liquid extraction, protein precipitation, and the like.
[0004] The pretreatment methods of liquid-liquid extraction and solid-liquid extraction methods require multiple steps such as dilution, multiple extractions, rotary evaporation, nitrogen drying, and purification. The process is cumbersome and requires a lot of manual operation. In addition, liquid-liquid extraction is difficult to achieve high throughput and automation. Although solid-liquid extraction can achieve high throughput, the sample extraction process mainly relies on SLE plates, and the cost of consumables is high.
[0005] At present, there are also many patent applications for sample pretreatment using protein precipitation method for the determination of fat-soluble vitamins in serum and plasma. However, there are generally problems such as low detection accuracy and recovery rate of reference substances, which leads to low sensitivity. It is also easy to cause blockages in pipelines or chromatographic columns. Some even require further extraction after protein precipitation before subsequent detection and analysis, which requires more manual operations for clinical testing, which is not conducive to clinical promotion and use.
[0006] In view of this, the present invention is proposed. Summary of the invention
[0007] The object of the present invention is to provide an internal standard solution for extracting fat-soluble vitamins in serum or plasma, a pretreatment reagent and a pretreatment method for detection. The internal standard solution provided in the embodiment of the present invention can improve the accuracy and recovery rate of the reference substance, thereby improving the sensitivity of the detection.
[0008] The present invention is achieved in that:
[0009] In a first aspect, the present invention provides an internal standard solution for extracting fat-soluble vitamins in serum or plasma, wherein the internal standard solution comprises methanol, acetonitrile, isopropanol and a modifier, wherein the volume ratio of the isopropanol, the methanol and the acetonitrile is: (28-32)%: (5-20)%: (50-65)%, and the concentration of the modifier in the internal standard solution is 40-60 mmol / L.
[0010] In an optional embodiment, the volume ratio of the isopropanol, the methanol and the acetonitrile is: 30%: (5-20)%: (50-65)%.
[0011] In an optional embodiment, the modifier is selected from ammonium acid substances, preferably ammonium formate or ammonium acetate.
[0012] In an optional embodiment, the internal standard solution further comprises an antioxidant.
[0013] In an optional embodiment, the concentration of the antioxidant in the internal standard solution is 2-7 mg / ml;
[0014] Preferably, the antioxidant is selected from any one or a combination of at least two of vitamin C, tea polyphenols, 2,6-di-tert-butyl-p-cresol and butylated hydroxyanisole.
[0015] In a second aspect, the present invention provides a pretreatment reagent for detecting fat-soluble vitamins in serum or plasma, which comprises a protein precipitant and the internal standard solution described in the aforementioned embodiment.
[0016] In an optional embodiment, the protein precipitant is selected from ammonium salts or halogenated carboxylic acids; more preferably, any one or a combination of at least two of zinc sulfate, trichloroacetic acid, ammonium sulfate and ammonium chloride;
[0017] Preferably, the protein precipitant is added in the form of a solvent;
[0018] Preferably, the concentration of the solvent formed by the protein precipitant is 0.1-0.3 mol / L, and the volume ratio of the solvent formed by the protein precipitant to the internal standard solution is (1:25)-(1:50).
[0019] In a third aspect, the present invention provides a pretreatment method for detecting fat-soluble vitamins in serum or plasma, comprising: mixing a sample with the pretreatment reagent for detecting fat-soluble vitamins in serum or plasma described in the aforementioned embodiment for pretreatment.
[0020] In an optional embodiment, the fat-soluble vitamins include at least one of VA, 25(OH)VD2, 25(OH)VD3 and VE.
[0021] The present invention has the following beneficial effects: the internal standard solution provided in the embodiment of the present invention adopts methanol, isopropanol, acetonitrile and a modifier, and limits their contents, thereby improving the accuracy and recovery rate of the reference substance, and then improving the sensitivity of detection. DETAILED DESCRIPTION
[0022] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.
[0023] First, an embodiment of the present invention provides an internal standard solution for extracting fat-soluble vitamins in serum or plasma, wherein the internal standard solution comprises methanol, acetonitrile, isopropanol and a modifier, wherein the volume ratio of the isopropanol, the methanol and the acetonitrile is: (28-32)%: (5-20)%: (50-65)%, and the total volume ratio of the isopropanol, the methanol and the acetonitrile is 100%.
[0024] Specifically, the volume ratio of isopropanol methanol to the acetonitrile is any value between (28-32)%: (5-20)%: (50-65)% such as 30:5:65, 30:15:55, 30:20:50, 28:7:65, 32:15:53, etc., and the preferred ratio is 30%: (5-20)%: (50-65)%.
[0025] Further, the modifier is selected from ammonium acid substances, such as but not limited to ammonium formate or ammonium acetate. The concentration of the modifier in the internal standard solution is 40-60mmol / L, such as 40mmol / L, 45mmol / L, 50mmol / L, 55mmol / L and 60mmol / L, etc., any value between 40-60mmol / L.
[0026] Although the combination of the above-mentioned methanol, isopropanol, acetonitrile and modifier can improve the detection accuracy and recovery rate of the reference substance, the shelf life of the internal standard solution is short. In order to further extend the shelf life of the internal standard solution, the internal standard solution of the embodiment of the present invention also includes an antioxidant.
[0027] The addition of an antioxidant to the internal standard solution of the embodiment of the present invention can not only extend the shelf life of the internal standard solution, but also ensure the effect of the internal standard solution and improve the detection accuracy and recovery rate of the reference substance.
[0028] Further, the antioxidant is selected from any one or a combination of at least two of vitamin C, tea polyphenols, 2,6-di-tert-butyl-p-cresol and butylated hydroxyanisole. The concentration of the antioxidant in the internal standard solution is 2-7 mg / ml; for example, any value between 2-7 mg / ml such as 2 mg / ml, 3 mg / ml, 4 mg / ml, 5 mg / ml, 6 mg / ml and 7 mg / ml.
[0029] The above-mentioned internal standard solution can be used to precipitate proteins, and then realize the detection of fat-soluble vitamins in serum or plasma. However, the above-mentioned may still be prone to clogging, causing pipeline blockage, or chromatographic column blockage and other problems. Therefore, an embodiment of the present invention provides a pretreatment reagent for the detection of fat-soluble vitamins in serum or plasma, which includes a protein precipitant and the internal standard solution described in the above-mentioned embodiment.
[0030] This pretreatment reagent can not only improve the accuracy and recovery rate of the reference material, and then improve the sensitivity of the detection, but also improve the problems of easy blockage causing pipeline blockage or chromatographic column blockage.
[0031] Specifically, the protein precipitant is selected from ammonium salts or halogenated carboxylic acids; for example, any one or a combination of at least two of zinc sulfate, trichloroacetic acid, ammonium sulfate and ammonium chloride.
[0032] Further, the protein precipitant is added in the form of a solvent. The concentration of the solvent is 0.1-0.3 mol / L, for example, any value between 0.1-0.3 mol / L such as 0.1 mol / L, 0.2 mol / L and 0.3 mol / L. The volume ratio of the solvent formed by the protein precipitant to the internal standard solution is (1:25)-(1:50). For example, any value between (1:25)-(1:50) such as 1:25, 1:30, 1:40 and 1:50.
[0033] In a third aspect, the present invention provides a pretreatment method for detecting fat-soluble vitamins in serum or plasma, comprising: mixing a sample with the pretreatment reagent for detecting fat-soluble vitamins in serum or plasma described in the aforementioned embodiment for pretreatment.
[0034] The specific operations are as follows:
[0035] 1. Take 50 μL of sample (calibrator, quality control, serum sample) and add it to a 1.6 mL 96-well plate; 2. Add 200 μL of internal standard solution, then add 20 μL of 0.2 mol / L zinc sulfate solution, and vortex mix at 1500 rpm for 20 min;
[0036] 3. Place in a centrifuge and centrifuge at 5000 rpm for 15 minutes;
[0037] 4. Take 200 μL of supernatant into another clean 330 μL 96-well low-adsorption plate;
[0038] Among them, the fat-soluble vitamins include at least one of VA, 25(OH)VD2, 25(OH)VD3 and VE.
[0039] After the pretreatment, the samples were tested by high performance liquid chromatography tandem mass spectrometry. Specifically, the test conditions were as follows:
[0040] Liquid phase gradient
[0041] Time (min) 0 0.4 0.8 1.8 2 4 4.3 5.4 5.5 6.0 Flow rate (μL / mL) 680 680 680 680 820 820 820 820 680 680 B% 55 55 85 85 90 90 95 95 55 55
[0042] The elution solvent is one or more of methanol, acetonitrile, pure water, and isopropanol.
[0043] The column temperature is 30-60°C, the flow rate is 0.5-0.9 mL / min, and the chromatographic column is C18.
[0044] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.
[0045] Example 1
[0046] The embodiment of the present invention provides an internal standard solution, the composition of which is as follows: isopropanol: methanol: acetonitrile is 30%: 15%: 55%, and the modifier is ammonium acetate, and its concentration in the internal standard solution is 50mmol / L.
[0047] The embodiment of the present invention provides a pretreatment reagent, which includes the above-mentioned internal standard solution and a protein precipitant, the concentration of the protein precipitant is 0.2 mol / L, the amount of the protein precipitant added is 20 μl, and the amount of the internal standard solution reagent added is 200 μL.
[0048] According to Regulation No. YY_T 1789.2-2021 Performance Evaluation Method for In Vitro Diagnostic Test Systems Part 2: Correctness, the accuracy of the reference material is calculated and the results are shown in the table below.
[0049]
[0050] Note 1: RECIPE above refers to quality control material, and NIST refers to reference material.
[0051] Note 2: According to the regulation YY_T 1789.2-2021 Performance evaluation method for in vitro diagnostic test systems Part 2: Accuracy, the accuracy rate between 85-115% meets the requirements.
[0052] The recovery results are shown in the following table.
[0053]
[0054] Example 2-Example 4
[0055] The embodiments of the present invention provide a method for detecting fat-soluble vitamins in serum using high performance liquid chromatography tandem mass spectrometry. The operation is basically the same as that of Example 1, except that the composition of the pretreatment reagent is different, as follows:
[0056] Example 2: The ratio of isopropanol:methanol:acetonitrile in the pretreatment reagent is 30%:5%:65%, and the selection and concentration of the other reagents are consistent with those in Example 1.
[0057] The accuracy of the reference material and the results are shown in the table below.
[0058] Sample VA 25(OH)VD2 25(OH)VD3 VE accuracy accuracy accuracy accuracy S1 100 105 103 99 S2 94 86.1 97 104 S3 101 106 89 107 S4 96.3 97.7 106 101 S5 102 99.5 102 97 S6 100 106 104 96.6 LQC 94.5 86.3 96.8 95.4 MQC 94.6 102 95.1 86.9 HQC 98 109 107 97.1 RECIPE-VD1 / 115 85.8 / RECIPE-VD2 / 101 86 / NIST1 115 / / 114 NIST2 83 / / 101
[0059] The recovery results are shown in the following table.
[0060]
[0061] Example 3: The ratio of isopropanol:methanol:acetonitrile in the pretreatment reagent is 30%:20%:50%, and the selection and concentration of other reagents are consistent with those in Example 1.
[0062] The accuracy of the reference material and the results are shown in the table below.
[0063]
[0064]
[0065] The recovery results are shown in the following table.
[0066]
[0067] Example 4: The composition and content of the pretreatment reagent are consistent with those of Example 1, the only difference being that an antioxidant, vitamin C, is additionally added. The concentration of vitamin C is 0.2 mol / l and the added amount is 20 μl.
[0068] The accuracy of the reference material and the results are shown in the table below.
[0069]
[0070] The recovery results are shown in the following table.
[0071]
[0072]
[0073] Comparative Examples 1-5
[0074] This comparative example provides a method for detecting fat-soluble vitamins in serum using high performance liquid chromatography tandem mass spectrometry, and its operation is basically the same as that of Example 1, except that the composition of the pretreatment reagent is different, as follows:
[0075] Comparative Example 1: The ratio of isopropanol:methanol:acetonitrile in the pretreatment reagent is 20%:40%:40%, and the selection and concentration of other reagents are consistent with those in Example 1.
[0076] The accuracy of the reference material and the results are shown in the table below.
[0077] Sample VA 25(OH)VD2 25(OH)VD3 VE accuracy accuracy accuracy accuracy S1 100 102 106 97 S2 94 99.5 89.4 103 S3 101 87.2 88.9 106 S4 95.3 89.1 93 100 S5 92 111 112 97 S6 100 111 111 96.6 LQC 94.6 96.1 149 93.4 MQC 94.6 103 117 86.9 HQC 98 108 128 97.1 RECIPE-VD1 / 118 113 / RECIPE-VD2 / 92.9 86 / NIST1 93 / / 84 NIST2 85 / / 98
[0078] The recovery results are shown in the following table.
[0079]
[0080] According to the above comparative examples, changing isopropanol, methanol and acetonitrile leads to a decrease in the accuracy of the reference material, and at the same time, the recovery rate does not meet the requirements.
[0081] Comparative Example 2
[0082] Isopropanol: methanol: acetonitrile in the pretreatment reagent is 25%: 40%: 35%, and the selection and concentration of other reagents are consistent with Example 1.
[0083] The accuracy of the reference material and the results are shown in the table below.
[0084] Sample VA 25(OH)VD2 25(OH)VD3 VE accuracy accuracy accuracy accuracy S1 100 104 104 97 S2 94 89.3 92.1 103 S3 94 99.7 96.5 105 S4 95.3 99.4 96.3 82 S5 92 102 103 97 S6 100 105 108 96.6 LQC 94.6 108 103 93.4 MQC 94.6 102 111 86.9 HQC 98 116 126 97.1 RECIPE-VD1 / 120 158 / RECIPE-VD2 / 112 110 / NIST1 96 / / 88 NIST2 87 / / 100
[0085] The recovery results are shown in the following table.
[0086]
[0087] According to the above comparative examples, changing isopropanol, methanol and acetonitrile leads to a decrease in the accuracy of the reference material, and at the same time, the recovery rate does not meet the requirements.
[0088] According to the above comparative examples, changing isopropanol, methanol and acetonitrile leads to a decrease in the accuracy of the reference material, and at the same time, the recovery rate does not meet the requirements.
[0089] Comparative Example 3
[0090] The ratio of isopropanol:methanol:acetonitrile in the pretreatment reagent is 40%:10%:50%, and the selection and concentration of other reagents are consistent with those in Example 1.
[0091] The accuracy of the reference material and the results are shown in the table below.
[0092] Sample VA 25(OH)VD2 25(OH)VD3 VE accuracy accuracy accuracy accuracy S1 90 104 101 97 S2 95 89 103 100 S3 93 103 85.2 105 S4 95.3 98.8 107 88 S5 90 103 103 96 S6 100 102 101 97 LQC 94.6 112 103 94.4 MQC 94.6 99.5 103 88.9 HQC 98 101 115 95.1 RECIPE-VD1 / 125 96.7 / RECIPE-VD2 / 128 86.6 / NIST1 96 / / 88 NIST2 87 / / 100
[0093] The recovery results are shown in the following table.
[0094]
[0095] According to the above comparative examples, changing isopropanol, methanol and acetonitrile leads to a decrease in the accuracy of the reference material, and at the same time, the recovery rate does not meet the requirements.
[0096] Comparative Example 4
[0097] The pretreatment reagent does not include a modifier, and the other compositions and contents are consistent with those in Example 1. The recovery results are as follows:
[0098]
[0099] It can be seen that in this application, if the recovery rate does not meet the requirements after removing the modifier, it further illustrates that the pretreatment reagent of the embodiment of the present invention can improve the accuracy and recovery rate of the reference substance detection.
[0100] The pretreatment reagent in Comparative Example 5 does not include a protein precipitant, and other compositions and contents are consistent with those in Example 1.
[0101] The chromatographic columns and liquid phases of Example 1 and Comparative Example 6 were managed for a certain period of time, wherein the detection method was to record the use of the columns and liquid phase pipelines in a record sheet. The results are shown in the following table.
[0102] Column usage time limit Liquid pipeline usage time limit Example 1 1 year 6 months Comparative Example 6 3 months 2 months
[0103] The pretreatment reagents of Example 1, Example 4 and Comparative Example 5 were tested for their shelf life using a real-time stability record (reference material accuracy comparison).
[0104] The results are as follows:
[0105]
[0106] It can be seen that the use of the pretreatment reagent provided in the embodiment of the present invention can effectively extend its shelf life.
[0107] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. An internal standard solution for extracting fat-soluble vitamins from serum or plasma, It is characterized in that The internal standard solution comprises methanol, acetonitrile, isopropanol and a modifier, wherein the volume ratio of the isopropanol, the methanol and the acetonitrile is: (28-32)%: (5-20)%: (50-65)%, and the concentration of the modifier in the internal standard solution is 40-60m mol / L.
2. The internal standard solution according to claim 1, It is characterized in that The volume ratio of the isopropanol, the methanol and the acetonitrile is: 30%: (5-20)%: (50-65)%.
3. The internal standard solution according to claim 1, It is characterized in that The improver is selected from ammonium acid substances, preferably ammonium formate or ammonium acetate.
4. The internal standard solution according to claim 1, It is characterized in that The internal standard solution also includes an antioxidant.
5. The internal standard solution according to claim 4, It is characterized in that The concentration of the antioxidant in the internal standard solution is 2-7 mg / ml; Preferably, the antioxidant is selected from any one or a combination of at least two of vitamin C, tea polyphenols, 2,6-di-tert-butyl-p-cresol and butylated hydroxyanisole.
6. A pretreatment reagent for detecting fat-soluble vitamins in serum or plasma, It is characterized in that The invention comprises a protein precipitant and the internal standard solution according to claim 1.
7. The pretreatment reagent according to claim 6, It is characterized in that The protein precipitant is selected from ammonium salts or halogenated carboxylic acids; more preferably, any one or a combination of at least two of zinc sulfate, trichloroacetic acid, ammonium sulfate and ammonium chloride; Preferably, the protein precipitant is added in the form of a solvent; Preferably, the concentration of the solvent formed by the protein precipitant is 0.1-0.3 mol / L, and the volume ratio of the solvent formed by the protein precipitant to the internal standard solution is (1:25)-(1:50).
8. A pretreatment method for detecting fat-soluble vitamins in serum or plasma, It is characterized in that include: The sample is mixed with the pretreatment reagent for detecting fat-soluble vitamins in serum or plasma as claimed in claim 6 for pretreatment.
9. The pretreatment method for detecting fat-soluble vitamins in serum or plasma according to claim 8, It is characterized in that The fat-soluble vitamins include VA, 25(OH)VD 2 , 25(OH)VD 3 and at least one of VE.
10. The pretreatment method for detecting fat-soluble vitamins in serum or plasma according to claim 8, It is characterized in that The method for detecting the fat-soluble vitamins in the serum or plasma is high performance liquid chromatography tandem mass spectrometry.
Citation Information
Cited By
Olanzapine blood concentration detection method
CN120908352A
A method for detecting olanzapine blood concentration
CN120908352B
Detection method and detection kit for five fat-soluble vitamins in dried blood spot
CN121068797A
